Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 219423
Company: AZURITY
Company: AZURITY
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| WIDAPLIK | AMLODIPINE BESYLATE; INDAPAMIDE; TELMISARTAN | EQ 1.25MG BASE;0.625MG;10MG | TABLET;ORAL | Prescription | None | Yes | No |
| WIDAPLIK | AMLODIPINE BESYLATE; INDAPAMIDE; TELMISARTAN | EQ 2.5MG BASE;1.25MG;20MG | TABLET;ORAL | Prescription | None | Yes | No |
| WIDAPLIK | AMLODIPINE BESYLATE; INDAPAMIDE; TELMISARTAN | EQ 5MG BASE;2.5MG;40MG | TABLET;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/05/2025 | ORIG-1 | Approval | Type 4 - New Combination | STANDARD |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219423s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/219423Orig1s000ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 06/05/2025 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/219423s000lbl.pdf |